	Diagnostic and treatment delays in penile cancer: a call to improve awareness and referral. World J Urol Negri F, Basile G, Galdieri A, Longoni M, Raffo M, Pozzi E, Belladelli F, Folcia A, Malvestiti M, Mercinelli C, Necchi A, Colecchia M, Briganti A, Montorsi F, Salonia A, Bandini M. PMID: 41779237 [PubMed - in process]
	[Treatment of metastatic hormone-sensitive prostate cancer]. Urologie Grimm MO, Leucht K, Marx M, Sperling M, Albarghouth MH. PMID: 41779146 [PubMed - as supplied by publisher]
	Single-cell transcriptomic profiling combined with Mendelian randomization illuminates molecular drivers of bladder cancer. Mol Genet Genomics He J, Jiang Z, Peng S, Peng L, Xia Z, Ma T, Tan X, Long Q, Wu J. PMID: 41779063 [PubMed - in process]
	Association of blood levels of forever plastics with lung cancer mortality among ever smokers in the Prostate Lung Colorectal and Ovarian (PLCO) cohort study. Clin Cancer Res Irajizad E, Fahrmann JF, Wu R, Rudsari H, Dennison JB, Ostrin E, Ajani J, Hanash S. PMID: 41779007 [PubMed - as supplied by publisher]
	Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC). Clin Cancer Res Slovin S, Gao X, Wei XX, Oh DY, McKay RR, Falchook G, Hussain A, McKean M, Wibmer A, Ho A, Eskew JD, Belani R, Coronella J, Haag S, Martin CE, McCaigue J, Mendoza J, Murphy A, Namini H, Spear MA, Shedlock DJ, Dorff TB. PMID: 41779004 [PubMed - as supplied by publisher]
	131I-LNTH-1095 Radioligand Therapy Plus Enzalutamide vs. Enzalutamide Alone in Men With PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study. Clin Cancer Res Yu EY, Narayan V, Esposito G, Szmulewitz R, Lu Y, Lilly MB, Calais J, Bratslavsky G, Menda Y, Vasanawala M, Pouliot F, Laidley D, Fleshner N, Saad F, Provost JC, Teslenko I, Rawat NK, Ulaner G. PMID: 41779000 [PubMed - as supplied by publisher]
	PSMA PET/CT in diagnosing and staging high grade prostate cancer: accuracy and cost-effectiveness. Arch Ital Urol Androl Pepe P, Pepe L, Pepe G, Fiorentino V. PMID: 41778990 [PubMed - as supplied by publisher]
	Requirement for Written Informed Consent and Selection Bias in a Chart-Review Prostate Cancer Study. Am J Epidemiol Zheng R, Das SK, Tran TD, Friedrich NA, Cummings SM, Gonzalez A, De Hoedt AM, Bellerose H, Hoffmeyer A, Van de Ven TJ, Freedland SJ. PMID: 41778894 [PubMed - as supplied by publisher]
	Plasma and urine biomarker algorithm versus systematic biopsy for prostate cancer detection in elderly men: a randomised trial with early termination for futility. Scand J Urol Pedersen TB, Poulsen CA, Lund M, Albitar M, Østergaard LD, Feddersen S, Lund L, Poulsen MH. PMID: 41778764 [PubMed - in process]
	Examining the prevalence and predictors of anxiety and depression across treatment stages in prostate cancer: a systematic review. Ecancermedicalscience Adesina OE, Akingbade O, Adesuyi EO, Tola Y, Adeyemi OB, Akintunde T, Osei S, Maitanmi J, Esan DT. PMID: 41778183 [PubMed]
	Label-free fluorescence lifetime imaging for rapid discrimination of high-grade prostate cancer in fresh biopsy cores: a feasibility study. J Biomed Opt Bec J, Zhou X, Tipirneni Y, Chen S, Qi J, Iczkowski KA, Dall'Era M, Marcu L. PMID: 41778026 [PubMed - in process]
	Clinical Characteristics and Prognostic Factors of Renal Sarcoma: A Japanese National Cancer Registry Study. Cancer Invest Kondo H, Ogura K, Morizane C, Satake T, Iwata S, Toda Y, Muramatsu S, Takemori T, Kobayashi E, Higashi T, Kawai A. PMID: 41777120 [PubMed - as supplied by publisher]
	Nutritional and Lifestyle Interventions for Prostate Cancer Patients Undergoing Radiotherapy: A Systematic Review. Nutr Cancer Han Y, Gong Y, Zhang W, Liang Y, Jia Z, Yang L, Zhang H. PMID: 41776849 [PubMed - as supplied by publisher]
	A domain-adaptive deep contrastive network for magnetic resonance imaging-driven bladder cancer classification. NPJ Digit Med Huang J, Hu H, Sun M, Wu W, Xu K, Xu J, Sun X, Hu D, Yao D, He T, Wei W, Song B, Fang L. PMID: 41775791 [PubMed - as supplied by publisher]
	Efficacy and Safety of Intravesical Gemcitabine and Docetaxel Combination Therapy in Patients With Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Clin Genitourin Cancer Doma, Hanusz K, Zapa, Shah P, Scilipoti P, Zapa, Pradere B, Moschini M, Boorjian SA, Radziszewski P, . PMID: 41775643 [PubMed - as supplied by publisher]
	Advances and challenges of PET imaging in bladder cancer-An update and future trends. Semin Nucl Med Mena E, Lindenberg L, Heng S, Choyke PL. PMID: 41775548 [PubMed - as supplied by publisher]
	Does protocol heterogeneity in active surveillance influence clinical outcomes? Insights from a multicenter prostate cancer cohort. Investig Clin Urol Ko YH, Ryu JH, Kim YB, Shin TJ, Kim BH. PMID: 41775447 [PubMed - in process]
	Preoperative selective arterial embolization followed by transurethral resection of bladder tumor for large bladder tumors: Early clinical experiences. Investig Clin Urol Bang S, Joo SM, Kim DK, Kwon JK, Bang S, Shin D, Jeon J, Hong SH, Cho KS. PMID: 41775446 [PubMed - in process]
	Diagnostic performance of narrow-band imaging and photodynamic diagnosis compared to white light cystoscopy for non-muscle invasive bladder cancer: A network meta-analysis of randomized trials. Investig Clin Urol Choi SY, Yang YJ, Min KC, Lee YS, Choi J, Kim JH, Lee CU, Yang EJ, Tae JH. PMID: 41775443 [PubMed - in process]
	Polygenic risk and germline genetics for prostate cancer in Asians: Where do we stand? Investig Clin Urol Song SH, Hong SK. PMID: 41775441 [PubMed - in process]

Articles 1 - 20 / 176422

Page 1 of 8822



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy